HRSA has indicated it will allow a hospital to accelerate timelines for its offsite locations to begin participating in the 340B Drug Discount Program.
Previously, offsite locations were required to be reimbursable on a hospital’s most recently filed Medicare cost report and then registered with HRSA before patients seen at the offsite location could be 340B eligible. This new guidance allows hospitals to consider patients at new locations to be 340B eligible before the cost report where the new location is an allowable cost center is officially filed.
The hospital must also ensure the patients seen at the new offsite locations are meeting the 340B patient definitions. And new locations still need to be registered as child-sites with HRSA once the cost report is filed.
As with any 340B guidance change, hospitals should have updated policies and procedures to reflect the time frame of when patients are 340B eligible and to maintain auditable records.
If you would like additional information or further discuss this change in guidance, please reach out to one of our Apexus Certified 340B Experts.
